Gabizon A, Gabizon-Peretz S, Modaresahmadi S, La-Beck N
BMJ Oncol. 2025; 4(1):e000573.
PMID: 39885941
PMC: 11751825.
DOI: 10.1136/bmjonc-2024-000573.
Gatto M, Johnson M, Najahi-Missaoui W
Life (Basel). 2024; 14(6).
PMID: 38929656
PMC: 11204409.
DOI: 10.3390/life14060672.
Alvarez K, Rojas M
Heliyon. 2023; 9(9):e19861.
PMID: 37810138
PMC: 10559248.
DOI: 10.1016/j.heliyon.2023.e19861.
Vanbilloen W, Rechberger J, Anderson J, Nonnenbroich L, Zhang L, Daniels D
Pharmaceutics. 2023; 15(7).
PMID: 37513992
PMC: 10383584.
DOI: 10.3390/pharmaceutics15071804.
Gupta R, Salave S, Rana D, Karunakaran B, Butreddy A, Benival D
Pharmaceutics. 2023; 15(5).
PMID: 37242677
PMC: 10222274.
DOI: 10.3390/pharmaceutics15051435.
Structure and Function of Cationic and Ionizable Lipids for Nucleic Acid Delivery.
Sun D, Lu Z
Pharm Res. 2023; 40(1):27-46.
PMID: 36600047
PMC: 9812548.
DOI: 10.1007/s11095-022-03460-2.
Size effect of liposomes on centimeter-deep ultrasound-switchable fluorescence imaging and ultrasound-controlled release.
Liu Y, Yao T, Ren L, Yuan B
J Mater Chem B. 2022; 10(43):8970-8980.
PMID: 36285768
PMC: 9670236.
DOI: 10.1039/d2tb01343f.
Ultrasonic Film Rehydration Synthesis of Mixed Polylactide Micelles for Enzyme-Resistant Drug Delivery Nanovehicles.
Stepanova D, Pigareva V, Berkovich A, Bolshakova A, Spiridonov V, Grozdova I
Polymers (Basel). 2022; 14(19).
PMID: 36235958
PMC: 9571646.
DOI: 10.3390/polym14194013.
Tuning the immune system by nanoparticle-biomolecular corona.
Palmieri V, Caracciolo G
Nanoscale Adv. 2022; 4(16):3300-3308.
PMID: 36131704
PMC: 9419885.
DOI: 10.1039/d2na00290f.
Stability of DMPC Liposomes Externally Conjugated with Branched Polyglycerol.
Beketov A, Mikhailov I, Darinskii A
Int J Mol Sci. 2022; 23(16).
PMID: 36012408
PMC: 9408945.
DOI: 10.3390/ijms23169142.
Localization of Multi-Lamellar Vesicle Nanoparticles to Injured Brain Tissue in a Controlled Cortical Impact Injury Model of Traumatic Brain Injury in Rodents.
Whitener R, Henchir J, Miller T, Levy E, Krysiewicz-Bell A, Abrams E
Neurotrauma Rep. 2022; 3(1):158-167.
PMID: 35403102
PMC: 8985535.
DOI: 10.1089/neur.2021.0049.
Biophysical Characterization of Tolerogenic Lipid-Based Nanoparticles Containing Phosphatidylcholine and Lysophosphatidylserine.
Nguyen N, Chen M, Chak V, Balu-Iyer S
J Pharm Sci. 2022; 111(7):2072-2082.
PMID: 35108564
PMC: 11075660.
DOI: 10.1016/j.xphs.2022.01.025.
Biodistribution Study of Niosomes in Tumor-Implanted BALB/C Mice Using Scintigraphic Imaging.
de Silva L, Fu J, Htar T, Wan Kamal W, Kasbollah A, Muniyandy S
Front Pharmacol. 2022; 12:778396.
PMID: 35069200
PMC: 8777053.
DOI: 10.3389/fphar.2021.778396.
Rational design of a nanoparticle platform for oral prophylactic immunotherapy to prevent immunogenicity of therapeutic proteins.
Nguyen N, Glassman F, Dingman R, Shenoy G, Wohlfert E, Kay J
Sci Rep. 2021; 11(1):17853.
PMID: 34497305
PMC: 8426360.
DOI: 10.1038/s41598-021-97333-0.
Liposomes and Extracellular Vesicles as Drug Delivery Systems: A Comparison of Composition, Pharmacokinetics, and Functionalization.
van der Koog L, Gandek T, Nagelkerke A
Adv Healthc Mater. 2021; 11(5):e2100639.
PMID: 34165909
PMC: 11468589.
DOI: 10.1002/adhm.202100639.
Megalin-targeting liposomes for placental drug delivery.
Alfaifi A, Heyder R, Bielski E, Almuqbil R, Kavdia M, Gerk P
J Control Release. 2020; 324:366-378.
PMID: 32461116
PMC: 8247794.
DOI: 10.1016/j.jconrel.2020.05.033.
Modified Spraying Technique and Response Surface Methodology for the Preparation and Optimization of Propolis Liposomes of Enhanced Anti-Proliferative Activity against Human Melanoma Cell Line A375.
Refaat H, Naguib Y, Elsayed M, Sarhan H, Alaaeldin E
Pharmaceutics. 2019; 11(11).
PMID: 31661945
PMC: 6921042.
DOI: 10.3390/pharmaceutics11110558.
Characterization of a liposomal copper(II)-quercetin formulation suitable for parenteral use.
Chen K, Anantha M, Leung A, Kulkarni J, Militao G, Wehbe M
Drug Deliv Transl Res. 2019; 10(1):202-215.
PMID: 31482519
PMC: 6978430.
DOI: 10.1007/s13346-019-00674-7.
Preparation and Characterization of PLA-PEG-PLA/PEI/DNA Nanoparticles for Improvement of Transfection Efficiency and Controlled Release of DNA in Gene Delivery Systems.
Amani A, Kabiri T, Shafiee S, Hamidi A
Iran J Pharm Res. 2019; 18(1):125-141.
PMID: 31089350
PMC: 6487431.
Doxorubicin-loaded red blood cells reduced cardiac toxicity and preserved anticancer activity.
Lucas A, Lam D, Cabrales P
Drug Deliv. 2019; 26(1):433-442.
PMID: 30929538
PMC: 6450495.
DOI: 10.1080/10717544.2019.1591544.
